In the second analyzed case, TLR expression on different CD3-CD56+ and CD3+CD56+ subtypes is particularly effective in differentiating GC patients from healthy individuals, with exceptionally high efficiency compared to the control group. This evidence concerns the gene NCAM1 and gastric cancer.